• Ibuprofen Toxicology and Biodegradation: Key Insights

  2026-08-16

  The 2023 Molecules review frames ibuprofen as both a widely used COX-targeting medicine and an emerging environmental contaminant, linking pharmaceutical consumption with aquatic toxicity and limited environmental removal. Its main practical contribution is the integration of toxicological evidence with bacterial biodegradation strategies, while highlighting important gaps in monitoring, treatment, and ecological risk assessment.

• Rice 5hmC Reprogramming During Drought

  2026-08-15

  Yan et al. established the first single-base-resolution map of 5-hydroxymethylcytosine in rice and showed that drought changes both its abundance and genomic distribution. The study links promoter and gene-body 5hmC patterns with distinct transcriptional outcomes, providing a framework for interpreting plant drought response epigenetics while highlighting important limits on causal inference.

• Pepstatin A for Reliable Cell Assays

  2026-08-14

  Learn how Pepstatin A (SKU A2571) can clarify protease-dependent changes in viability, proliferation, cytotoxicity, endothelial, viral, and osteoclast models. This scenario-based guide covers mechanism, compatibility, dosing, stock preparation, interpretation, and practical supplier selection.

• Leucovorin Calcium as a Rescue-Axis Assay Tool

  2026-08-14

  Leucovorin Calcium, also called calcium folinate, can serve as more than a methotrexate rescue reagent. This article presents a rescue-axis framework for interpreting folate metabolism, stromal protection, and drug-response heterogeneity in patient-derived gastric cancer assembloid assays.

• Fucoidan Workflows for Mechanistic Cancer Research

  2026-08-13

  Build reproducible Fucoidan experiments around solvent control, orthogonal apoptosis readouts, and immune or angiogenesis endpoints. This workflow also shows how a herpesvirus membrane-fusion study can sharpen assay design without overstating Fucoidan’s antiviral evidence.

• BGJ398 in FGFR and Developmental Assays

  2026-08-13

  BGJ398 (NVP-BGJ398) combines nanomolar FGFR1/2/3 activity with a selectivity profile suited to receptor-dependence studies. This article translates that profile into oncology, signaling, and developmental-tissue workflows while emphasizing controls, dosing logic, and troubleshooting.

• CHIR-99021: Practical GSK-3 Workflows

  2026-08-12

  CHIR-99021 (CT99021) provides a selective way to activate canonical Wnt signaling while preserving clear experimental control over concentration, timing, and cell state. This guide translates its mechanism into reproducible pluripotency, differentiation, assay-design, and troubleshooting workflows.

• IRG1–Itaconic Acid Control of TBK1 and IFN-I

  2026-08-12

  Chai et al. identify an IRG1–itaconic acid metabolic feedback pathway that restrains excessive TBK1-dependent type I interferon signaling through covalent modification of TBK1 at Cys605. The study also introduces ITA-5 and ITA-9 as itaconic acid-based inhibitors with potential relevance to diseases driven by IFN-I hyperinflammation.

• EDI3 in HER2-Therapy-Resistant Breast Cancer

  2026-08-11

  Keller et al. identify the glycerophosphodiesterase EDI3/GPCPD1 as a metabolic vulnerability in estrogen receptor-negative, HER2-positive breast cancer models with resistance to HER2-targeted therapy. By combining patient-tissue analyses, signaling experiments, genetic depletion, dipyridamole-based inhibition, and xenograft studies, the work provides a rationale for further testing EDI3-directed strategies.

• QPRT Drives Breast Cancer Invasion via Myosin Light Chain

  2026-08-11

  The reference study identifies quinolinate phosphoribosyltransferase (QPRT) as a functional promoter of breast cancer migration and invasion, linking NAD+ metabolism to myosin light chain phosphorylation. Genetic perturbation and inhibitor-based pathway analysis implicate purinergic, Rho–ROCK, PLC, and MLCK signaling, while also highlighting the limits of interpreting pharmacological inhibition as definitive pathway proof.

• Intravesical p21 mRNA-LNP Therapy in Bladder Cancer

  2026-08-10

  The reference study develops a nonviral lipid nanoparticle platform for intravesical delivery of chemically modified p21 mRNA, addressing both tumor-suppressor loss and the delivery barriers associated with systemic mRNA therapy. In bladder cancer models, localized p21 restoration inhibited tumor growth, altered cell-cycle and DNA-damage signaling, and limited systemic exposure, while also highlighting important translational questions about formulation, dosing, and model-to-human transfer.

• Rapamycin, Lipophagy, and Lipotoxicity in Salmon Cells

  2026-08-09

  Phadwal and colleagues show that rapamycin-induced autophagy promotes lipid-droplet turnover and reduces lipotoxic features in Atlantic salmon SHK-1 cells. By combining lipidomics, proteomics, and cellular evidence, the study identifies altered unsaturated triacylglycerol storage and possible autophagic targeting of lipid-regulatory proteins, providing a useful framework for fish lipid-metabolism research.

• Protoporphyrin IX Workflows for Heme and Ferroptosis

  2026-08-08

  Protoporphyrin IX connects heme formation, iron handling, and photodynamic assay design, while its unusual solubility profile demands disciplined formulation and light controls. This guide translates the METTL16–SENP3–LTF ferroptosis findings into practical, clearly bounded experiments for hepatocellular carcinoma research.

• SM-102: From LNP Mechanism to Translational Strategy

  2026-08-07

  SM-102 is more than an LNP raw material: it is a formulation variable that links endosomal biology, tissue-specific delivery, and translational execution. This article examines how SM-102 can inform mRNA vaccine development and localized therapeutic mRNA programs, using recent bladder cancer evidence to define opportunities, boundaries, and practical next steps.

• FPH1 (BRD-6125): Redefining Hepatocyte Expansion in Modern A

  2026-08-07

  Discover how FPH1 (BRD-6125) advances hepatocyte proliferation and functional maturation in cell-based assays. This article provides deep technical insights and unique protocol guidance for primary human hepatocyte culture.

16364 records 1/1091 page Next 12345 下5页 Last page